Page 1 | Search Results | Blood | American Society of Hematology

1-20 of 155

Sort by

Sort Order Select

Journal Articles

Hydroxyurea reduces infections in children with sickle cell anemia in Uganda

Ruth Namazzi, Caitlin Bond, Andrea L. Conroy, Dibyadyuti Datta, Abner Tagoola, Michael J. Goings, Jeong Hoon Jang, Russell E. Ware, Robert Opoka, Chandy C. John

Blood (2024) 143 (14): 1425–1428.

https://doi.org/10.1182/blood.2023021575

Published: 2024

Includes: Supplemental data

Journal Articles

Pharmacokinetic-Guided Hydroxyurea to Reduce Transfusion Requirements in Ugandan Children with Sickle Cell Anemia: Baseline Data from the Alternative Dosing and Prevention of Transfusions (ADAPT) Trial

Alexandra Power-Hays, Ruth Namazzi, Charles Kato, Andrea Conroy, Heather Ann Hume, Chandy C. John, Susan E. Stuber, Adam C. Lane, Teresa S. Latham, Robert Opoka, Russell E. Ware

Blood (2023) 142 (Supplement 1): 1156.

https://doi.org/10.1182/blood-2023-181058

Published: 2023

Journal Articles

Effects of L-Glutamine on Biomarkers of Response in Sickle Cell Disease: A Pharmacokinetics-Pharmacodynamics Analysis

Alina Sadaf, Min Dong, Jennifer Korpik, Amanda Pfeiffer, Theodosia A. Kalfa, Teresa S. Latham, Alexander A. Vinks, Russell E. Ware, Charles T. Quinn

Blood (2023) 142 (Supplement 1): 1145.

https://doi.org/10.1182/blood-2023-180312

Published: 2023

Journal Articles

Hydroxyurea Improves Intelligence Quotient Scores in Children with Sickle Cell Anemia and Elevated Transcranial Doppler Velocity

Angela E Rankine-Mullings, Deanne Soares, Karen Aldred, Susan Chang-Lopez, Margaret Elizabeth Wisdom-Phipps, William Schultz, Teresa S. Latham, Susan E. Stuber, Patrice Jackson, Russell E. Ware, Marvin Ellsworth Reid

Blood (2023) 142 (Supplement 1): 797.

https://doi.org/10.1182/blood-2023-188160

Published: 2023

Journal Articles

A Novel, Rapid, and Accurate Quantitative Hydroxyurea Assay

Kathryn McElhinney, Luke R. Smart, Thad Alan Howard, Alexandra Power-Hays, Russell E. Ware

Blood (2023) 142 (Supplement 1): 2530.

https://doi.org/10.1182/blood-2023-190100

Published: 2023

Journal Articles

Hydroxyurea Dose Optimization Is Safe and Improves Outcomes for Children with Sickle Cell Anemia Living in Sub-Saharan Africa: The Reach Experience

Banu Aygun, Adam C. Lane, Luke R. Smart, Leon Tshilolo, Thomas N. Williams, Peter Olupot-Olupot, Brigida Santos, Susan E. Stuber, George A. Tomlinson, Teresa S. Latham, Russell E. Ware

Blood (2023) 142 (Supplement 1): 6.

https://doi.org/10.1182/blood-2023-172919

Published: 2023

Journal Articles

Prospective Identification of Variables As Outcomes for Treatment (PIVOT): A Phase II Clinical Trial of Hydroxyurea for Children and Adults with HbSC Disease

Catherine I. Segbefia, Luke R. Smart, Susan E. Stuber, Priscilla Ekpale, Kwesi N. Amissah-Arthur, Klenam Dzefi-Tettey, Enoch Mensah, Adam C. Lane, Diana Dwuma-Badu, Teresa S. Latham, Yvonne Dei-Adomakoh, Russell E. Ware

Blood (2023) 142 (Supplement 1): 3877.

https://doi.org/10.1182/blood-2023-190351

Published: 2023

Journal Articles

Hydroxyurea treatment is associated with lower malaria incidence in children with sickle cell anemia in sub-Saharan Africa

Peter Olupot-Olupot, George Tomlinson, Thomas N. Williams, Léon Tshilolo, Brígida Santos, Luke R. Smart, Kathryn McElhinney, Thad A. Howard, Banu Aygun, Susan E. Stuber, Adam Lane, Teresa S. Latham, Russell E. Ware

Blood (2023) 141 (12): 1402–1410.

https://doi.org/10.1182/blood.2022017051

Published: 2023

Includes: Supplemental data

Journal Articles

Hydroxyurea with Dose Escalation to Reduce Primary Stroke Risk in Children with Sickle Cell Anemia in Dominican Republic: The Sacred Trial

Rosa M. Nieves, Teresa Latham, Nicolle Marte, Luisanna Sanchez, Melissa E. Berges, Gabriela S. Urcuyo, Carla Florencio, Carla Gonzalez, Paola Del Villar, Sheena Chen, Paula Reyes, Daniel Ramirez, Euladys Matos, Manuel Marinez, Susan E. Stuber, William Schultz, Adam Lane, Rafael Mena, Russell E. Ware

Blood (2022) 140 (Supplement 1): 451–452.

https://doi.org/10.1182/blood-2022-168324

Published: 2022

Journal Articles

Hydroxyurea Pharmacokinetics in Young Children with Sickle Cell Anemia: Results from the Therapeutic Response Evaluation and Adherence Trial (TREAT)

Min Dong, Angela Good, Alexander A. Vinks, Russell E. Ware, Patrick T. McGann

Blood (2022) 140 (Supplement 1): 8168–8169.

https://doi.org/10.1182/blood-2022-171022

Published: 2022

Journal Articles

Hydroxyurea with Dose-Escalation to Reduce Primary Stroke Risk in Children with Sickle Cell Anemia in Tanzania: Primary Results of the Sphere Trial

Emmanuela E. Ambrose, Teresa Latham, Primrose Songoro, Mwesige Charles, Adam Lane, Susan E. Stuber, Abel Nkono Makubi, Russell E. Ware, Luke R. Smart

Blood (2022) 140 (Supplement 1): 447–448.

https://doi.org/10.1182/blood-2022-164787

Published: 2022

Journal Articles

Hydroxyurea Pharmacokinetics and Fetal Hemoglobin Response in Ugandan Children with Sickle Cell Anemia

Alexandra Power-Hays, Min Dong, Kathryn McElhinney, Andrea L. Conroy, Teresa Latham, Adam Lane, Robert O. Opoka, Alexander A. Vinks, Russell E. Ware

Blood (2022) 140 (Supplement 1): 5461–5462.

https://doi.org/10.1182/blood-2022-170839

Published: 2022

Journal Articles

Evaluation of Dosage and Food Effect on L-Glutamine Exposure for Sickle Cell Anemia: A Population Pharmacokinetic Analysis

Min Dong, Alina Sadaf, Alexander A. Vinks, Russell E. Ware, Charles T. Quinn

Blood (2022) 140 (Supplement 1): 8256–8257.

https://doi.org/10.1182/blood-2022-167550

Published: 2022

Journal Articles

Reproductive equity: preserve the reserve

Charles T. Quinn, Russell E. Ware

Blood (2022) 139 (7): 963–965.

https://doi.org/10.1182/blood.2021015021

Published: 2022

Journal Articles

Pharmacokinetics of L-Glutamine (Endari) in Pediatric and Adult Sickle Cell Disease Patients: A Phase 4, Open-Label, Single-Center Study

Alina Sadaf, Min Dong, Amanda Pfeiffer, Teresa Latham, Alexander A. Vinks, Russell E. Ware, Charles T. Quinn

Blood (2021) 138 (Supplement 1): 980.

https://doi.org/10.1182/blood-2021-147631

Published: 2021

Journal Articles

Hydroxyurea Reduces the Transfusion Burden in Children with Sickle Cell Anemia: The Reach Experience

Alexandra Power-Hays, George A. Tomlinson, Leon Tshilolo, Brigida Santos, Thomas N. Williams, Peter Olupot-Olupot, Patrick T. McGann, Banu Aygun, Adam Lane, Susan E. Stuber, Teresa Latham, Russell E. Ware

Blood (2021) 138 (Supplement 1): 11.

https://doi.org/10.1182/blood-2021-146632

Published: 2021

Journal Articles

Effect of Hydroxyurea Therapy on the Incidence of Infections in Ugandan Children with Sickle Cell Anaemia

Ruth Namazzi, Andrea L. Conroy, Caitlin Bond, Micheal J. Goings, Dibyadyuti Datta, Russell E. Ware, Jeong Hoon Jang, Chandy C. John, Robert O. Opoka

Blood (2021) 138 (Supplement 1): 765.

https://doi.org/10.1182/blood-2021-153559

Published: 2021

Journal Articles

Increased oxygen affinity: to have and to hold

Charles T. Quinn, Russell E. Ware

Blood (2021) 138 (13): 1094–1095.

https://doi.org/10.1182/blood.2021013243

Published: 2021

Journal Articles

Microscope diagnosis of MYH9-related thrombocytopenia

Alina Sadaf, Russell E. Ware

Blood (2021) 138 (11): 1000.

https://doi.org/10.1182/blood.2021012044

Published: 2021

Journal Articles

There’s safety in numbers

Russell E. Ware, Stephen D. Dertinger

Blood (2021) 137 (6): 729–731.

https://doi.org/10.1182/blood.2020010033

Published: 2021

NARROW

Hydroxyurea reduces infections in children with sickle cell anemia in Uganda

Pharmacokinetic-Guided Hydroxyurea to Reduce Transfusion Requirements in Ugandan Children with Sickle Cell Anemia: Baseline Data from the Alternative Dosing and Prevention of Transfusions (ADAPT) Trial

Effects of L-Glutamine on Biomarkers of Response in Sickle Cell Disease: A Pharmacokinetics-Pharmacodynamics Analysis

Hydroxyurea Improves Intelligence Quotient Scores in Children with Sickle Cell Anemia and Elevated Transcranial Doppler Velocity

A Novel, Rapid, and Accurate Quantitative Hydroxyurea Assay

Hydroxyurea Dose Optimization Is Safe and Improves Outcomes for Children with Sickle Cell Anemia Living in Sub-Saharan Africa: The Reach Experience

Prospective Identification of Variables As Outcomes for Treatment (PIVOT): A Phase II Clinical Trial of Hydroxyurea for Children and Adults with HbSC Disease

Hydroxyurea treatment is associated with lower malaria incidence in children with sickle cell anemia in sub-Saharan Africa

Hydroxyurea with Dose Escalation to Reduce Primary Stroke Risk in Children with Sickle Cell Anemia in Dominican Republic: The Sacred Trial

Hydroxyurea Pharmacokinetics in Young Children with Sickle Cell Anemia: Results from the Therapeutic Response Evaluation and Adherence Trial (TREAT)

Hydroxyurea with Dose-Escalation to Reduce Primary Stroke Risk in Children with Sickle Cell Anemia in Tanzania: Primary Results of the Sphere Trial

Hydroxyurea Pharmacokinetics and Fetal Hemoglobin Response in Ugandan Children with Sickle Cell Anemia

Evaluation of Dosage and Food Effect on L-Glutamine Exposure for Sickle Cell Anemia: A Population Pharmacokinetic Analysis

Reproductive equity: preserve the reserve

Pharmacokinetics of L-Glutamine (Endari) in Pediatric and Adult Sickle Cell Disease Patients: A Phase 4, Open-Label, Single-Center Study

Hydroxyurea Reduces the Transfusion Burden in Children with Sickle Cell Anemia: The Reach Experience

Effect of Hydroxyurea Therapy on the Incidence of Infections in Ugandan Children with Sickle Cell Anaemia

Increased oxygen affinity: to have and to hold

Microscope diagnosis of MYH9-related thrombocytopenia

There’s safety in numbers

Email alerts

ASH Publications

American Society of Hematology

Email alerts

ASH Publications

American Society of Hematology

This Feature Is Available To Subscribers Only